Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence.
Romeo-Guitart D, Forés J, Herrando-Grabulosa M, Valls R, Leiva-Rodríguez T, Galea E, González-Pérez F, Navarro X, Petegnief V, Bosch A, Coma M, Mas JM, Casas C. Romeo-Guitart D, et al. Among authors: mas jm. Sci Rep. 2018 Jan 30;8(1):1879. doi: 10.1038/s41598-018-19767-3. Sci Rep. 2018. PMID: 29382857 Free PMC article.
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
Artigas L, Coma M, Matos-Filipe P, Aguirre-Plans J, Farrés J, Valls R, Fernandez-Fuentes N, de la Haba-Rodriguez J, Olvera A, Barbera J, Morales R, Oliva B, Mas JM. Artigas L, et al. Among authors: mas jm. PLoS One. 2020 Oct 2;15(10):e0240149. doi: 10.1371/journal.pone.0240149. eCollection 2020. PLoS One. 2020. PMID: 33006999 Free PMC article.
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach.
Carcereny E, Fernández-Nistal A, López A, Montoto C, Naves A, Segú-Vergés C, Coma M, Jorba G, Oliva B, Mas JM. Carcereny E, et al. Among authors: mas jm. Oncotarget. 2021 Feb 16;12(4):316-332. doi: 10.18632/oncotarget.27875. eCollection 2021 Feb 16. Oncotarget. 2021. PMID: 33659043 Free PMC article.
Antigen-stimulated PBMC transcriptional protective signatures for malaria immunization.
Moncunill G, Scholzen A, Mpina M, Nhabomba A, Hounkpatin AB, Osaba L, Valls R, Campo JJ, Sanz H, Jairoce C, Williams NA, Pasini EM, Arteta D, Maynou J, Palacios L, Duran-Frigola M, Aponte JJ, Kocken CHM, Agnandji ST, Mas JM, Mordmüller B, Daubenberger C, Sauerwein R, Dobaño C. Moncunill G, et al. Among authors: mas jm. Sci Transl Med. 2020 May 13;12(543):eaay8924. doi: 10.1126/scitranslmed.aay8924. Sci Transl Med. 2020. PMID: 32404508
47 results